放射性碘治疗未改善甲状腺许特莱细胞癌的癌症特异性生存
基于SEER数据库2000至2018年接受全甲状腺切除术的2279例甲状腺许特莱细胞癌患者,采用Kaplan-Meier法和Cox比例风险回归评估癌症特异性生存,并进行倾向性评分匹配分析。结果显示放射性碘治疗与总体队列或倾向性评分匹配队列的癌症特异性生存改善均无显著关联,亚组分析结果相似。
要点
- 放射性碘治疗与甲状腺许特莱细胞癌患者的癌症特异性生存改善无显著关联。
- 倾向性评分匹配队列及侵袭性特征亚组中结果一致(所有P > .05)。
- 该信息可能有助于这些患者放射性碘治疗的决策。
核心结论
- 放射性碘治疗对甲状腺许特莱细胞癌患者的癌症特异性生存无统计学显著影响。
研究设计与样本
- 从SEER数据库识别2000至2018年接受全甲状腺切除术的甲状腺许特莱细胞癌患者,共2279例。
- 采用Kaplan-Meier法和Cox比例风险回归模型评估癌症特异性生存,并进行倾向性评分匹配分析以控制潜在混杂因素。
主要发现
- 在总体队列或倾向性评分匹配队列中,放射性碘治疗与癌症特异性生存改善均无显著关联。
- 亚组分析显示相似结果,即使在年龄55岁或以上、肿瘤大小大于40 mm、SEER分期远处转移、甲状腺外侵犯和淋巴结转移的患者中亦然(所有P > .05)。
临床怎么用
- 作者认为该信息可能有助于这些患者放射性碘治疗的决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: It is unclear whether radioactive iodine (RAI) therapy could improve cancer-specific survival (CSS) in patients with Hürthle cell carcinoma (HCC) of the thyroid. OBJECTIVE: To investigate the effect of RAI on CSS in HCC patients. METHODS: HCC patients who underwent total thyroidectomy (TT) were identified from the Surveillance, Epidemiology, and End Results (SEER) database between 2000 and 2018. The Kaplan-Meier method and the Cox proportional hazards regression model were used to evaluate CSS. Propensity score-matched (PSM) analyses were performed to control the influence of potential confounders. RESULTS: A total of 2279 patients were identified. RAI treatment was not significantly associated with improved CSS in overall or PSM cohort. Subgroup analyses indicated similar results, even in patients with aggressive features such as age 55 years or older, tumor size greater than 40 mm, distant disease in SEER staging, extrathyroidal extension, and lymph node metastases (all P > .05). CONCLUSION: RAI has no statistically significant influence on the CSS in HCC patients. This information may aid in decision-making for RAI therapy in these patients.
引用
- Wang X, Zheng X, Zhu J, et al. Radioactive Iodine Therapy Does not Improve Cancer-specific Survival in Hürthle Cell Carcinoma of the Thyroid. J Clin Endocrinol Metab. 2022. PMID: 35908290. doi:10.1210/clinem/dgac448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。